Related news from
Tue, 15 Jul 2025 17:37:00 +0000	Sightview Expands Leadership Bench, Appointing Vice Presidents of Client Operations and Product Management DURHAM, N.C., July 15, 2025--Sightview, the only EHR and practice management partner focused solely on eyecare, has appointed Melissa Wright and Casi Nestelroad as VPs.
Tue, 15 Jul 2025 17:25:55 +0000	Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion Cencora (COR) recently executed a distribution services agreement with Citius Oncology, signaling an expansion in its pharmaceutical distribution capabilities. Over the past quarter, Cencora’s share price rose by 4.4%, aligning with the market trend of major indexes reaching record highs. This gain is supported by several corporate actions, including strong second-quarter earnings and ongoing share buybacks, which may have bolstered investor confidence. The dividend announcement and...
Tue, 15 Jul 2025 13:12:00 +0000	BD Partners With Waters to Build High-Volume Diagnostics Leader BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.
Tue, 15 Jul 2025 13:02:00 +0000	Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings? BSX eyes strong Q2 with MedSurg momentum, solid Cardiovascular growth and benefits from key tech acquisitions.
Mon, 14 Jul 2025 12:29:00 +0000	ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.
Mon, 14 Jul 2025 12:07:00 +0000	Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms BIO surges 4% as the Stilla acquisition fuels the launch of four ddPCR systems, expanding to 400K+ assay offerings.
Sat, 12 Jul 2025 18:40:11 +0000	Cencora, Inc. (COR): If It Was Down, I’d Say “Double Down And Buy,” Says Jim Cramer We recently published Jim Cramer’s Fresh 14 Stocks & Thoughts About Market Performance. Cencora, Inc. (NYSE:COR) is one of the stocks Jim Cramer recently discussed. Cencora, Inc. (NYSE:COR) is an American pharmaceutical and healthcare services provider. It is a rare stock in its peers that is in the green this year. Cencora, Inc. (NYSE:COR)’s shares […]
Fri, 11 Jul 2025 16:10:04 +0000	Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Fri, 11 Jul 2025 13:57:00 +0000	InspireMD Launches CGuard Prime Carotid Stent System in the U.S. NSPR unveils FDA-approved CGuard Prime in the United States, targeting safer carotid procedures and stroke prevention.
Fri, 11 Jul 2025 12:02:00 +0000	Here's Why You Should Add Cencora Stock to Your Portfolio Now COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks.
Thu, 10 Jul 2025 16:09:00 +0000	Reasons to Add Fresenius Medical Stock to Your Portfolio Now FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
Thu, 10 Jul 2025 12:21:00 +0000	ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise? Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.
Thu, 10 Jul 2025 12:19:00 +0000	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.
Thu, 10 Jul 2025 12:19:00 +0000	Should You Continue to Hold STERIS Stock in Your Portfolio Now? STE rides on strong Healthcare and AST growth, but macro pressures and customer consolidation cloud its outlook.
Thu, 10 Jul 2025 12:18:00 +0000	Is it Worth Adding Boston Scientific Stock to Your Portfolio Now? BSX rides on strong MedSurg growth and strategic acquisitions amid currency headwinds.
Wed, 09 Jul 2025 16:04:00 +0000	AMN Stock Gains Post Latest Deals With symplr to Boost Operations AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.
Wed, 09 Jul 2025 15:57:00 +0000	Here's Why You Should Add PacBio Stock to Your Portfolio Now PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.
Wed, 09 Jul 2025 12:29:00 +0000	Alcon Stock Gains Following UNITY VCS' Approval in Canada ALC's UNITY VCS gets Canada's approval, advancing surgical precision with faster, more efficient technology.
Wed, 09 Jul 2025 12:21:00 +0000	Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? TMO's growth via acquisitions and product launches is strong, but macro pressures and FX headwinds cloud the outlook.
Tue, 08 Jul 2025 13:22:00 +0000	Paysafe and Champion Homes have been highlighted as Zacks Bull and Bear of the Day PSFE earns Bull of the Day with deep value and rising earnings, while SKY's short surge and weak outlook land it as Bear of the Day.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!